These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis of amino acid derived seven-membered lactams by RCM and their evaluation against HIV protease. Zaman S; Campaner P; Abell AD Bioorg Med Chem; 2006 Dec; 14(24):8323-31. PubMed ID: 17010620 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors. Huang PP; Randolph JT; Klein LL; Vasavanonda S; Dekhtyar T; Stoll VS; Kempf DJ Bioorg Med Chem Lett; 2004 Aug; 14(15):4075-8. PubMed ID: 15225729 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of N-acyl azacyclic urea HIV-1 protease inhibitors with high potency against multiple drug resistant viral strains. Zhao C; Sham HL; Sun M; Stoll VS; Stewart KD; Lin S; Mo H; Vasavanonda S; Saldivar A; Park C; McDonald EJ; Marsh KC; Klein LL; Kempf DJ; Norbeck DW Bioorg Med Chem Lett; 2005 Dec; 15(24):5499-503. PubMed ID: 16203141 [TBL] [Abstract][Full Text] [Related]
10. Development of a concise and diversity-oriented approach for the synthesis of plecomacrolides via the diene-ene RCM. Lu K; Huang M; Xiang Z; Liu Y; Chen J; Yang Z Org Lett; 2006 Mar; 8(6):1193-6. PubMed ID: 16524301 [TBL] [Abstract][Full Text] [Related]
11. Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Rodgers JD; Lam PY; Johnson BL; Wang H; Li R; Ru Y; Ko SS; Seitz SP; Trainor GL; Anderson PS; Klabe RM; Bacheler LT; Cordova B; Garber S; Reid C; Wright MR; Chang CH; Erickson-Viitanen S Chem Biol; 1998 Oct; 5(10):597-608. PubMed ID: 9818151 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein effects of cyclic urea HIV protease inhibitor DMP 323 in competitional absorption studies. Richter M; Gyémánt N; Molnár J; Hilgeroth A Arch Pharm (Weinheim); 2006 Nov; 339(11):625-8. PubMed ID: 17048292 [TBL] [Abstract][Full Text] [Related]
14. Expeditious synthesis of enantiopure symmetrical macroheterocycles by ring-closing metathesis of ether and tether-linked 1,2-O-isopropylidenefuranosides. Biswas G; Sengupta J; Nath M; Bhattacharjya A Carbohydr Res; 2005 Mar; 340(4):567-78. PubMed ID: 15721326 [TBL] [Abstract][Full Text] [Related]
15. Sustainable synthesis of diverse privileged heterocycles by palladium-catalyzed aerobic oxidative isocyanide insertion. Vlaar T; Cioc RC; Mampuys P; Maes BU; Orru RV; Ruijter E Angew Chem Int Ed Engl; 2012 Dec; 51(52):13058-61. PubMed ID: 23161862 [TBL] [Abstract][Full Text] [Related]
16. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors. Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase. Sammond DM; Nailor KE; Veal JM; Nolte RT; Wang L; Knick VB; Rudolph SK; Truesdale AT; Nartey EN; Stafford JA; Kumar R; Cheung M Bioorg Med Chem Lett; 2005 Aug; 15(15):3519-23. PubMed ID: 15990302 [TBL] [Abstract][Full Text] [Related]
18. Total synthesis of macrosphelides A, B, and E: first application of ring-closing metathesis for macrosphelide synthesis. Kawaguchi T; Funamori N; Matsuya Y; Nemoto H J Org Chem; 2004 Jan; 69(2):505-9. PubMed ID: 14725466 [TBL] [Abstract][Full Text] [Related]
19. P-heterocyclic building blocks: application to the stereoselective synthesis of P-sugars. Stoianova DS; Whitehead A; Hanson PR J Org Chem; 2005 Jul; 70(15):5880-9. PubMed ID: 16018681 [TBL] [Abstract][Full Text] [Related]
20. Asymmetric synthesis of oxygen heterocycles via Pd-catalyzed dynamic kinetic asymmetric transformations: application to nucleosides. Trost BM; Brown BS; McEachern EJ; Kuhn O Chemistry; 2003 Sep; 9(18):4442-51. PubMed ID: 14502631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]